Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)
China
· Delayed Price · Currency is CNY 9.94
+0.14 (1.43%)
Mar 11, 2026, 9:25 AM CST
SHA:603520 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,358 | 3,810 | 4,823 | 6,694 | 15,886 | 16,099 | Upgrade
|
| Market Cap Growth | 15.58% | -21.00% | -27.95% | -57.86% | -1.32% | 125.95% | Upgrade
|
| Enterprise Value | 6,721 | 5,711 | 7,239 | 8,716 | 17,059 | 17,207 | Upgrade
|
| Last Close Price | 9.94 | 8.57 | 13.80 | 18.95 | 44.43 | 44.70 | Upgrade
|
| PE Ratio | - | - | 109.03 | - | 49.07 | 67.44 | Upgrade
|
| Forward PE | 58.47 | 17.38 | 23.53 | 23.90 | 37.04 | 45.75 | Upgrade
|
| PS Ratio | 1.82 | 1.62 | 2.20 | 3.14 | 7.94 | 11.78 | Upgrade
|
| PB Ratio | 1.67 | 1.45 | 2.74 | 3.78 | 7.17 | 8.63 | Upgrade
|
| P/TBV Ratio | 2.29 | 1.98 | 4.66 | 6.38 | 11.16 | 14.56 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 77.51 | 755.35 | Upgrade
|
| P/OCF Ratio | 12.98 | 19.69 | 108.25 | - | 31.22 | 92.27 | Upgrade
|
| EV/Sales Ratio | 2.81 | 2.43 | 3.30 | 4.09 | 8.53 | 12.59 | Upgrade
|
| EV/EBITDA Ratio | 21.59 | 20.27 | 21.86 | 29.25 | 28.69 | 36.36 | Upgrade
|
| EV/EBIT Ratio | 109.97 | 90.98 | 47.76 | 62.64 | 38.67 | 49.58 | Upgrade
|
| EV/FCF Ratio | -434.28 | - | - | - | 83.23 | 807.36 | Upgrade
|
| Debt / Equity Ratio | 1.00 | 0.99 | 1.74 | 1.57 | 0.86 | 0.98 | Upgrade
|
| Debt / EBITDA Ratio | 8.40 | 9.23 | 9.23 | 9.29 | 3.20 | 3.85 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 9.31 | 85.44 | Upgrade
|
| Net Debt / Equity Ratio | 0.90 | 0.77 | 1.42 | 1.20 | 0.48 | 0.48 | Upgrade
|
| Net Debt / EBITDA Ratio | 7.61 | 7.15 | 7.52 | 7.11 | 1.79 | 1.88 | Upgrade
|
| Net Debt / FCF Ratio | -152.26 | -7.02 | -11.24 | -3.85 | 5.18 | 41.79 | Upgrade
|
| Asset Turnover | 0.41 | 0.41 | 0.41 | 0.42 | 0.43 | 0.35 | Upgrade
|
| Inventory Turnover | 1.78 | 1.70 | 1.79 | 2.59 | 2.38 | 1.60 | Upgrade
|
| Quick Ratio | 0.36 | 0.39 | 0.36 | 0.50 | 0.81 | 0.89 | Upgrade
|
| Current Ratio | 0.89 | 0.83 | 0.77 | 0.79 | 1.09 | 1.27 | Upgrade
|
| Return on Equity (ROE) | -1.10% | -2.23% | 2.52% | -3.61% | 16.17% | 17.53% | Upgrade
|
| Return on Assets (ROA) | 0.65% | 0.68% | 1.75% | 1.71% | 5.93% | 5.50% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.25% | 1.41% | 3.66% | 3.88% | 12.20% | 10.67% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.70% | 1.90% | 5.90% | 5.50% | 14.70% | 12.00% | Upgrade
|
| Earnings Yield | -0.67% | -1.29% | 0.92% | -1.13% | 2.04% | 1.48% | Upgrade
|
| FCF Yield | -0.36% | -7.54% | -4.60% | -8.22% | 1.29% | 0.13% | Upgrade
|
| Dividend Yield | 2.04% | 1.75% | - | 2.64% | 0.80% | 0.80% | Upgrade
|
| Payout Ratio | - | - | 442.32% | - | 62.08% | 62.42% | Upgrade
|
| Buyback Yield / Dilution | 6.69% | -20.25% | 1.31% | -0.10% | -3.05% | -0.91% | Upgrade
|
| Total Shareholder Return | 8.72% | -18.50% | 1.31% | 2.54% | -2.25% | -0.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.